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Angelman Syndrome (AS) is a genetically determined syndrome that has 
a unique behavioral phenotype. This syndrome is described as jerky 
ataxia and an unusual happy facial expression with pathological laughter. 
Severe mental retardation is a unique feature of the syndrome, together 
with microbrachycephaly and abnormal electroencephalographic 
findings with or without clinical seizures. The patients cannot speak 
or at most, they have a vocabulary consisting only of a few words. 
The genetic abnormality of AS has been located on chromosome 
15q11-q13. Patients with AS mostly have deletions on the maternally 
derived allele (75–80%) while some of them show paternal uniparental 
disomy (~2%) or a rare imprinting mutation developmental disorder 
caused by deletion of the maternally-inherited chromosome 15q11–13. 
A 2.5-year-old girl is presented. Clinical suspicion of AS was raised 
at the age of 27 months when she presented with mental retardation 
and epilepsy, absence of speech, inability to gait and paroxysmal 
episodes of laughter. Moreover, she had facial dysmorphic features 
such as microbrachycephaly, mid-facial hypoplasia, macrostomia and 
a prominent mandible. Chromosomal analysis revealed 46 xx with the 
deletion of 15q chromosome (15q11q13-snrpn/ic) Our patient met the 
classical phenotype and genotype of AS. 
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Introduction
In 1965, Harry Angelman, an English pediatrician, reported 3 children with a 
similar pattern of mental retardation, seizures, ataxia, easily provoked laughter, 
absent speech and dysmorphic facial features (1). He called them “puppet 
children” because of the superficial resemblance to puppets in view of their flat 
head, jerky movements, protruding tongue and bouts of laughter.
His observations were confirmed over the next decade by other clinicians, and 
a pejorative term called “happy puppet syndrome” was introduced, not only 
referring to their gait but also to their joyous facial expression and fits of 
inappropriate laughter(2). Williams and Frias proposed the term “Angelman’s 
syndrome”.
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Over 450 AS individuals have now been reported 
including familial cases. The prevalence of AS is 
estimated to be around 1/10.000–1/20.000(3,4). AS is 
a clinical diagnosis that can be confirmed by either 
cytogenetic or DNA testing in about 80–85% of the 
cases. Patients with AS have a typical phenotype. 
Features of AS frequently become apparent at 1–4 
years of age, the average age at diagnosis is 6 years 
and the syndrome is characterized by dysmorphic 
cranio-facial features (micro-brachycephaly, mid-
facial hypoplasia, deep set eyes, macrostomia and 
prominent mandible), jerky ataxia and an unusual 
happy facial expression with pathological laughter 
and Severe mental retardation with or without clinical 
seizures (5-9). 
We report a patient with Angelman syndrome and 
describe its different features to help our physicians 
to have a more vivid picture of this condition.  
Case report
The patient, a 2.5-year-old girl, was the first child 
of healthy first-cousin parents. She was born at term 
gestation by spontaneous vaginal delivery and weighed 
normal for gestational age. She had a positive family 
history of epilepsy and mental retardation in her aunt 
and her cousin.  
Facial features included microcephaly (head 
circumference: 45.5 cm, below the 3rd percentile) 
with a wide mouth and protruded tongue, as well as 
mandibular prognathism. She had a happy disposition 
(already noted in infancy) with paroxysms of laughter 
(figure 1).
 Generalized tonic clonic seizures were presented 
from the age of 7 days which were treated promptly 
with phenobarbital. Seizures continued until the 
anticonvulsant was changed to primidon and clobazam. 
Concomitant EEG findings were markedly abnormal 
with generalized spike and poly spike waves. At the 
time of the diagnosis (age of 27 months), the patient 
demonstrated a marked neuro-developmental delay 
with severely impaired communication and lack of 
any recognizable speech. She was able to sit, but 
could not walk independently. A performed CT scan 
at that age was normal. Chromosomal analyses with 
karyotype (GTG) and fluorescent in situ hybridization 
(FISH) techniques revealed 46 xx with deletion of 
15q chromosome (15q11q13-snrpn/ic) (Figure 2-3). 
Discussion
Our patient in this study was diagnosed at the age of 
27 months with facial features including microcephaly 
and mental retardation. Other symptoms were absence 
of speech, inability to gait and paroxysmal episodes 
of laughter with a wide mouth, a protruded tongue and 
mandibular prognathism. She had a happy disposition 
with paroxysms of laughter (10-12).
In other studies, the features of AS frequently become 
apparent at 1-4 years of age with the average age at 
diagnosis being 6 years (10-12). The facial features 
evolve over the first 5 years of life. Typical features 
include brachycephaly and a head circumference 
below the 25th percentile (13). A horizontal occipital 
groove is found in 35% of the patients. The mouth 
is large, giving rise to widely spaced but otherwise 
normal teeth.
The chin is pointed and there is mandibular 
prognathism. The eyes are deep set and often blue. 
Strabismus is seen in about 40% of the patients (13). 
Severe visual problems are not common. Coarsening of 
facial features with increasing age has been reported, 
with marked mandibular prognathism, a pointed chin, 
macrostomia and a pronounced lower lip(14-16). 
All patients have severe mental retardation and delayed 
motor milestones. Jerky movements become apparent 
during the first few months and motor delay is obvious 
by nine months of age. The jerky movements, tongue 
thrusting, mouthing, and hand-flapping when walking, 
are all characteristic. Reflexes are brisk and the gait 
is slow, ataxic and stiff-legged with the characteristic 
posture of raised arms with flexed wrists and elbows. 
Almost all patients are ‘happy’ and smile frequently. 
Their laughter is provoked by minimal stimuli and is 
occasionally inappropriate (13-15). 
In this patient, seizure was present from the age of 
7 days and was treated promptly with phenobarbital. 
Seizures continued until the anticonvulsant was 
changed to primidon and clobazam. Concomitant 
EEG findings were markedly abnormal with spike and 
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poly spike generalized waves.
Studies demonstrate that epileptic seizures occur 
in about 80% of the patients with AS. Age at onset 
varies from 1 month to 5 years (mean 2–3 years). The 
initial symptoms of epilepsy are febrile convulsions 
in infancy in about 40% of the patients (17-18). 
In this patient, EEG findings were markedly abnormal 
with generalized spike and poly spike waves. There 
are specific EEG patterns in AS patients which may 
appear in isolation or in various combinations either 
in the same EEG recordings or at different times in the 
same patient (18-20). 
Computerized tomography (CT scan) findings in two 
studies were normal or showed cerebral atrophy and 
ventricular dilatation in a minority of the patients (13-
14). One report described an abnormally convoluted 
surface area of the cortex in the parietal lobe of the 
Sylvian fissure in the supramarginal gyrus, using 
specific techniques in MRI (Magnetic Resonance 
Imaging)(21). 
There is no specific therapy for AS patients. Epileptic 
seizures often need AEDs (Anti Epileptic Drugs) and 
good results are achieved with Valproic Acid and 
Clonazepam. Physiotherapy is very important for AS 
patients to keep them mobile as long as possible and 
to minimize orthopedic interventions. The use of non-
verbal communication is potentially useful for them, 
but attempts to train the use of signing to augment 
their speech may be unsuccessful due to their poor 
imitation skills and possible motor organizational 
difficulties (22).
In conclusion, This study demonstrated a typical 
manifestation of Angelman syndrome with facial 
features, mental retardation, delayed motor and 
seizures with EEG findings.
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 Fig 1. photos of the presented Case of AS.
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Fig 3.Chromosome study of the patient on the basis of fluorescent in situ hybridization: Fluorescent in situ 
hybridization was performed on metaphase sreads using the cytocell prader-willi/Angelman (SNRPN/IC)probe.
Conclussion:46XX,ish del(15)(q11q13)(SNRPN/IC)Compatible with prader- willi / Angelman syndrome.
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Fig 2.chromosome study of the patient on the basis of GTG technique: Twenty metaphase spreads were studied on the 
basis of GTG technique at 450-500 band resolution, revealing 46 chromosomes with possible deletion in long arm of 
chromosome 15 at q11q13 band.
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